References
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:562–569.
- World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO Guidelines Review Committee; 2013.
- The HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
- Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8:639–649.
- Lapolla A, Dalfrà MG, Mello G, et al. Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab. 2008;93:876–880.
- National Collaborating Centre for Women’s and Children’s Health. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. Vol. 3. London: RCOG Press; 2015. p. 1–680.
- Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553.
- Gardosi J, Francis A. A customised weight centile calculator. GROW v6.7.7. UK Gestation Network; 2015. Available from: www.gestation.net.
- Sweeting AN, Ross GP, Hyett J, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care. 2016;39:75–81.
- Jolly MC, Sebire NJ, Harris JP, et al. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:9–14.
- Vernini JM, Moreli JB, Magalhães CG, et al. Maternal and fetal outcomes in pregnancies complicated by overweight and obesity. Reprod Health. 2016;13:100.
- Gabbay-Benziv R, Reece EA, Wang F, et al. Birth defects in pregestational diabetes: defect range, glycemic threshold and pathogenesis. WJD. 2015;6:481–488.
- Sridhar SB, Ferrara A, Ehrlich SF, et al. Risk of large-for-gestational-age newborns in women with gestational diabetes by race and ethnicity and body mass index categories. Obstet Gynecol. 2013;121:1255–1262.
- Gunderson EP, Hurston SR, Ning X, et al. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study. Ann Intern Med. 2015;163:889–898.
- Kirk JK, D'Agostino RB, Bell RA, et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29:2130–2136.
- Hughes RC, Rowan J, Florkowski CM. Is there a role for HbA1c in pregnancy? Curr Diab Rep. 2016;16:5.
- Hughes RCE, Moore MP, Gullam JE, et al. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37:2953–2959.
- Mane L, Flores-Le Roux JA, Benaiges D, et al. Role of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort. J Clin Endocrinol Metab. 2017;102:390–397.
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–682.
- Corrado F, D’Anna RD, Cannata ML, et al. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab. 2012;38:458–461.
- Zhu WW, Yang HX, Wei YM, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013;36:586–590.